PAF effects on eicosanoid release in neonatal rat cardiomyocytes
The aim of this study was to find out whether, in neonatal rat cardiomyocytes, platelet-activating factor (PAF) can stimulate eicosanoid formation. For this purpose neonatal cardiomyocytes were incubated for 60 min at 37°C in HANKS buffer with PAF (10–1000 nM), and the eicosanoids thromboxane A 2 (T...
Gespeichert in:
Veröffentlicht in: | Prostaglandins, leukotrienes and essential fatty acids leukotrienes and essential fatty acids, 1995-09, Vol.53 (3), p.197-200 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The aim of this study was to find out whether, in neonatal rat cardiomyocytes, platelet-activating factor (PAF) can stimulate eicosanoid formation. For this purpose neonatal cardiomyocytes were incubated for 60 min at 37°C in HANKS buffer with PAF (10–1000 nM), and the eicosanoids thromboxane A
2 (TXA
2) and prostacyclin (PGI
2) were assessed in the supernatant as TXB
2 and 6-keto-PGF
1α, respectively, by an enzyme immunoassay. PAF caused concentration-dependent release of PGI
2; TXA
2, however, was significantly released only at the highest concentration of PAF (1000 nM). Acetylsalicylic acid (556 μM) and the PAF antagonist WEB 2086 (10 μM) significantly attenuated PAF-induced eicosanoid formation. We conclude that in neonatal rat cardiomyocytes PAF can induce eicosanoid formation and this effect is brought about by activation of a specific PAF receptor. |
---|---|
ISSN: | 0952-3278 1532-2823 |
DOI: | 10.1016/0952-3278(95)90116-7 |